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Interventional Neuroradiology: Henry Ford Hospital Experience
with Nonembolization Procedures
Clifford R. Jack, Jr, MD,* Bharat A. Mehta, MD,* Roushdy S. Boulos, MD, PhD,*
Suresh C. Patel, MD,* James I. Ausman, MD, PhD,+ and Ghaus M. Malik, MD^
Innovative technical developments over the past two decades have resulted in the development ofa
variety of useful interventional procedures for minimally invasive treatment of a variety of head and
neck lesions. We have had experience with four different types of nonembolization interventional
neuroradiologic procedures at Henry Ford Hospital from 1981 through 1985.
Percutaneous transluminal angioplasty of six external carotid artery stenoses has been performed
in five patients. Five were successful, and the artery became occluded in one patient. Intracarotid
BCNU infusion was performed successfully infivepatients with recurrent astrocytoma. Intraarterial
streptokinase infusion was performed in one patient with acute thrombosis of an ectatic basilar artery.
A traumatic carotid cavernous fistula was successfully closed by detachable silicone balloon
technique. (Henry FordHosp MedJ 1986,34:11-18)

T

he search for less invasive ways to treat a variety of abnormalities involving virtually every organ system has led to
rapid growth in the field of interventional radiology. In recent
years, interventional radiologic techniques have played an increasingly important role in the treatment of a variety of lesions
of the head, neck, and spine, giving rise to the high subspecialized field of interventional neuroradiology.
A number of technical innovations within the past two decades have stimulated the development of a variety of useful and
increasingly successful interventional neuroradiologic procedures. The list of therapeutic procedures that have been applied to the treatment of head and neck abnormalities include:
percutaneous transcatheter embolization of vascular tumors and
vascular malformation (1,2); percutaneous transluminal angioplasty (PTA) (3-9);ti-ansluminaldetachable, occlusive, and
leak-calibrated balloons (10-15); and intracranial drag infusion
made possible by better catheter delivery systems (16-20).
In fliis paper we discuss only the nonembolization interventional neuroradiologic procedures performed at Henry Ford
Hospital. Indications, benefits, risks, and technical guidelines
are discussed for each procedure.

Patients, Methods, and Results
Twelve patients have undergone nonembolization interventional neuroradiologic procedures at Henry Ford Hospital from
1981 through 1985. All procedures were performed by one of the
authors (Mehta) in the Department of Radiology, Division of
Neuroradiology. To date, we have experience with four different
types of nonembolization procedures.
Percutaneous transluminal angioplasty (PTA) of the external carotid artery (ECA)
Patients—Six such procedures have been performed in five
patients. Bilateral ECA-PTA was performed in the same sitting
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in one patient. All patients were elderly, with atherosclerotic occlusion of the ipsilateral intemal carotid artery (ICA) and atherosclerotic stenosis at the origin of the ipsilateral ECA. These
patients were to undergo superficial temporal artery to middle
cerebral artery bypass procedures but had ipsilateral external
carotid stenoses. The PTA was performed to eliminate the need
for extemal carotid endarterectomy before the bypass operation.
Technique—The procedure was performed via the femoral
approach in all but one patient, in whom a direct common carotid artery puncture was performed. A constant intravenous
heparin infusion was maintained throughout each procedure. A
5 French polyethylene Dotter Balloon Dilatarion Catheter
(Cook, Bloomington, IN) with a 4 mm (inflated diameter) balloon was positioned across the stenotic ECA lesion under fluoroscopic guidance. The balloon was inflated three times for 30
seconds each. The balloon catheter was then withdrawn into the
common carotid artery, and a postdilatation angiogram was
performed.
Results—Increase in lumen size of the affected segment of
50% to 70% was achieved in five arteries (Fig 1). No neurologic
complications were encountered in any of these patients.
The ECA became occluded in the patient who underwent direct carotid artery puncture. She developed a mild contralateral
hemiparesis following the procedure, which resolved in two
months. This patient was shown at subsequent endarterectomy
to have had a large, heavily calcified atherosclerotic plaque producing the stenosis.
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Fig I—External carotid PTA in patients with occluded ipsilateral ICA .(A) Predilatation and (B) postdilatation AP view right carotid
injection showing 50% increase in size of stenotic ECA segment (arrow).

Intracarotid L3-Bis(2-chloroethyl)-l-nitrosourea (BCNU)
infusion
Patients—Six such procedures have been perfonned in five
patients. These patients ranged in age from 27 to 60. All patients
had end stage, grade 3 to 4, unilateral supratentorial astrocytomas. All tumors were recurrent (postsurgical resection),
and all were then treated with a combined radiation therapyintracarotid chemotherapy approach.
Technique—Via transfemoral approach, a 5 French catheter
was placed in the petrosal segment of the ICA ipsilateral to the
tumor. Twenty-five grams of mannitol in saline were infused
through the catheter rapidly. A solution of 100 mg/m^ BCNU in
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49 mL of normal saline and 1 mL absolute ethanol (solvent for
BCNU) was then infused through the catheter via a micropump
(Sigma Motor, Inc, Middleport, NY) over 15 minutes. The patients were carefully monitored for signs of neurologic and
ocular toxicity during infusion.
Results—No neurologic deficit, seizure activity, vision loss,
myelosuppression, or GI toxicity was produced. One patient did
experience retro-orbital pain during infusion with no permanent
sequelae.
Results conceming survivorship or improved neurologic status are inconclusive in comparison to other chemotherapeutic
regimes due to the small number of patients included. All
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Fig 2(B)—Intraarterial streptokinase infusion for basilar artery
thrombosis. AP scout radiograph showing position of hollow
wire tip in midbasilar artery (arrows).

Fig2(A)—Intraarterial streptokinase infusionfor basilar artery
thrombosis. AP view of left vertebral artery injection showing
massive ectasia of basilar artery. A 3 cm thrombus partially
occludes rostral basilar artery (arrow).
patients did eventually die. Well-controlled data with documentation of the effect of intraarterial BCNU on tumor size by
computed tomography (CT) are not available.
Intraarterial streptokinase infusion for basilar artery
thrombosis
Patients—This procedure was performed on an emergency
basis in one patient. This 66-year-old man presented with
rapidly progressing multiple cranial nerve deficits and decreased level of consciousness over the course of several hours.
Emergency cerebral angiography demonstrated marked diffuse
ectasia ofthe basilar and the intracranial left vertebral artery
with nearly complete occlusion of the rostral basilar artery by a
3 cm intraluminal thrombus.
Technique—Twelve to 14 hours after onset of symptoms, the
interventional procedure was begun. A Berenstein catheter
(USCI, Bellerica, MA) was placed transfemorally into the cervical left vertebral artery at the C2 level. Through this, a 0.038
removable core hollow wire (USCI) was coaxially placed into
the basilar artery, just proximal to the thrombus. Through the
hoUow wire 350,000 units of streptokinase (Streptase, HoechstRoussel, NS) was infused over three hours using a microdrip
pump (Sigma Motor, Inc). This was accompanied by low-dose
systemic heparinization. The entire procedure was performed
on the angiography table, with constant monitoring of the patient's clinical status. Three angiographic studies were performed to assess morphologic change in the thrombus.
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Results—Slow but progressive improvement in the patient's
level of sensorium was noted over the first three hours of infusion. At three hours, however, a sudden decreased level of consciousness was noted, and the infusion was tenninated. Diagnostic angiographic studies performed over the course of the
streptokinase infusion demonstrated no change in thrombus
size.
The patient unfortunately died two days later. Autopsy revealed extensive brain stem and cerebellar infarction, producing
marked posterior fossa mass effect and tonsillar hemiation, with
no evidence of intracranial hemonhage (Fig 2). A recent embolus was also present in the left posterior cerebral artery, producing infarction of the left occipital lobe. The basilar artery was
markedly ectatic with little evidence of atherosclerosis and uniformly absent intemal elastic lamina. The thrombus appeared to
have formed without an atherosclerotic substrate, due to stasis
within the basilar artery.
Detachable balloon occlusion of carotid-cavernous fistula
Patient—This procedure has been performed in one patient to
date, a 64-year-old man who presented with a posttraumatic
high-flow carotid-cavemous fistula on the right. He was symptomatic from a constant loud brait that interfered with sleep and
a cavernous sinus syndrome consisting of ipsilateral cranial
nerve 3,4, and 6 palsy.
Technique—The procedure was performed using a BectonDickinson (Rutherford, NJ) detachable silicone balloon system
that comes premade from the manufacturer (12). The cylindric
siliconerabberballoon (2x7 mm uninflated) is attached to a 150
cm 3 French polyurethane catheter via a stainless steel pressureactivated valve pin. This balloon-tipped catheter was introduced
coaxially through a 9 French straight catheter that had been
placed transfemorally into the proximal right ICA. The balloon
wasflushedwith normal saline into thefismlaviaflowdirection
technique (12). The balloon was inflated wifli 0.6 mL of 210%
Amipaque (Winthrope-Breon Lab, New York, NY). A DSA ran
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Fig 2f C)—Intraarterial streptokinase infusion for basilar
artery thrombosis. AP left vertebral injection ctfter two and one
half hours of streptokinase infusion shows no change in size of
basilar thrombus (arrow), although the patient was improved
clinically at this point.
was taken to document satisfactory balloon position, effect on
fistula flow, and morphology of the adjacent carotid siphon.
When the aforementioned criteria had been met, the balloon was
detached. Two detachable silicone balloons were placed by this
technique.
Results—The first balloon was successfully placed into the
fistulous opening, resulting in immediate subjective cessation of Fig 2(D)—Intraarterial streptokinase infusion for basilar
artery thrombosis. Gross specimen of ectatic basilar circulation
the brait. After one hour, the brait retumed suddenly. A DSA
at autopsy.
study was performed that revealed migration of the baUoon from
thefistulousopening into the cavernous sinus with reopening of
flow through the fistula. A second balloon was then successfully of arterial stenosis involving many organ systems (6,7). This
technique has proved to be especially useful in the treatment of
placed into thefismlousopening, again with subjective relief of
coronary artery disease, peripheral vascular disease, and renothe brait. At one month follow-up, neither baUoon had changed
vascular hypertension (6,7).
position, and the patient remained asymptomatic (Fig 3). No
Several authors have reported the application of PTA in the
complications were encountered during placement of either baltreatment
of stenotic arterial lesions of the extracranial carotid
loon. Marked clinical improvement in the right cavemous sinus
and
vertebral
circulation. Successful dilatation of cervical ICA
syndrome was noted within 24 hours.
stenoses due tofibromusculardysplasia (8) and of carotid and
vertebral artery atherosclerotic stenoses (3,4) has been reported.
Discussion
Atherosclerotic stenosis of the cavemous-carotid artery has also
In recent years, interventional neuroradiologic procedures
been dilated successfully (9). Due to the risk of distal embolizahave increasingly been employed with much success in the man- tion and possible stroke, PTA for atherosclerotic ICA lesions is
agement of a variety of head and neck conditions. This paper is
recommended only for patients who are not surgical candidates
limited to a discussion of the four types of nonembolization in(3,4).
terventional neuroradiologic procedures to date at this
The risk of stroke is minimized in dUatation of ECA stenoses
institution.
in patients with ipsilateral ICA occlusion. Successful dilatation
of ECA stenosis in nine patients before superficial temporal to
Percutaneous transluminal angioplasty of the external
middle cerebral artery bypass for ICA stenosis without neucarotid artery
rologic complication has been reported by Vitek (5).
The technique of PTA was pioneered by Grantzig in the 1970s
This procedure is not without risk. An intimal tear or intraand has since been applied extensively in treatment of local areas
mural hematoma may be produced that could lead to ECA occlu-
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Fig 3(A)—Detachable balloon occlusion of carotid cavernous
fistula. CT scan showing enlargement of right cavernous sinus
(arrow) due to high-flow CCflstula.

Fig 2 (E)—/ntraart erial streptokinase infusion for basilar artery
thrombosis. Cross section of basilar artery showing intraluminal thrombus.
sion, as happened in one of our cases. Widefluctuationsin blood
pressure are also possible due to pressure on chemoreceptor
cells in the adjacent carotid bulb (3). Emboli may reach the intracranial circulation even with cervical ICA occlusion in patients
with reti-ograde ophthalmic collateral flow.
Poor results have been reported in attempting to dilate heavUy
calcified stenotic plaques (4). Both the poor results reported in
the literature as well as our experience with one patient in whom
PTA faUed leads us to concur that patients with calcified plaques
are not candidates for this procedure.
Intracarotid BCNU infusion in recurrent astrocytoma
Anaplastic glioma accounts for approximately one fourth of
all adult cerebral neoplasms and includes glioblastoma multiform, anaplastic astrocytoma, and malignant astrocytomas.
These tumors have a uniformly fatal course with less than 10%
survivorship at two years (21). A mean survival of 17 weeks is
reported with surgical resection alone (22). With the addition of
radiation therapy, mean survival is extended to 37.5 weeks (22).
The best result reported in patients treated with resection, radiation therapy, plus systemic BCNU is a survival of 51 weeks (22).
Although this combined approach has resulted in prolonged survival and improved neurologic function, the long-term prognosis remains poor (23-28).
BCNU does cross the blood-brain barrier and has been shown
to be the most effective single chemotherapeutic agent against
glioma (17,21). A response rate of 50% with a mean duration of
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Fig 3(B)—Detachable balloon occlusion of carotid cavernous
fistula. Lateral view of right ICA injection showing opacification of right cavernous sinus (hollow arrow) by flow through
fistula. Venous drainage is via inferior petrosal sinuses
bilaterally (solid arrows).
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silateral cerebral infarction is a less widely reported complication (16,18).
Supraophthalmic BCNU infusion through a microballoon or
hollow wire threaded coaxially through a polyurethane catheter
with its tip in the cervical ICA is possible (14,15). Successful
supraophthalmic BCNU infusion has been reported using calibrated leak microballoons with no retinal toxicity (28). Superselective catheterization of the specific intracranial vessels supplying the tumor may also be possible, in which case much of
the normal brain parenchyma ipsilateral to the tumor may be
spared exposure to high concentrations of BCNU. However, the
safety and efficacy of superselective intraarterial BCNU infusion directly into tumor vessels have not been definitively established, and this approach must, at this point, be regarded as
experimental.
Intracarotid mannitol was given in our series of patients to
temporarily modify the blood-brain barrier and to increase delivery of BCNU to tumortissuein our protocol (29). However,
the efflcacy of this step in achieving greater delivery of BCNU to
tumor tissue has recently been questioned (27).

Fig 3(C)—Detachable balloon occlusion of carotid cavernous
flstula. Lateral view of right ICA injection after flstula closure.
No opacification of cavernous sinus is present (compare with
Fig 3B). Two balloons are identifiable as subtracted images
(arrows).
nine months' response has been reported for recunent astrocytoma with systemic BCNU therapy alone (23). Unfortunately,
side effects of systemic treatment can be severe. Delayed myelosuppression (particularly thrombocytopenia) is the chief side
effect, with gastrointestinal toxicity also reported (18,23,24).
There is evidence indicating cumulative myelotoxicity for
BCNU, a problem limiting the total amount that may be given
(23,24).
The goal of intracarotid BCNU infusion is to achieve high intratumoral drag levels with low systemic levels, thereby maximizing antitumoral drag activity and minimizing systemic side
effects. Work with monkeys has shown that intraarterial BCNU
administration results in 190% to 280% higher brain, nucleic
acid-bound drag levels than systemic administration (17). Intracarotid BCNU has been shown to shrink astrocytomas by CT
criteria, though no remission has been documented with this
technique (20). Improved survivorship with this technique in
comparison to systemic BCNU administration has been reported in a series of 30 patients by Greenberg (22). However, no
randomized studies with this technique have been reported.
The majorriskreported for intracarotid BCNU infusion is ipsilateral retinal toxicity, including retro-orbital pain during infusion, retinal vasculitis, and even blindness (20,27). This is because the ophthalmic artery receives high drag concentration
with high cervical ICA catheter tip placement. Decreasing the
ethanol concentration of the mixmre seems to decrease the severity of retinal toxicity; however, it is not yet clear whether the
offending agent is ethanol alone, or BCNU as well (21,27). Ip-

16

Henry Ford Hosp Med J—Vol 34, No 1, 1986

Intraarterial streptokinase infusion for basilar artery
thrombosis
Basilar artery thrombosis has been a very poor prognosis. In a
series of 22 cases of angiographically proven basilar artery occlusion by Thompson et al, 44% of these patients died within
three months (30). Archer and Homstein published 20 cases of
angiographically proven basilar artery occlusion; 70% of these
patients died within three and a half months (31). Those patients
with rostral basilar artery thrombosis had an even poorer prognosis than those with more proximal occlusion (31). To date,
no effective surgical therapy is available for basilar artery
thrombosis.
Successful intraarterial clot lysis has been achieved using
both intravenous (IV) and intraarterial (IA) streptokinase
(19,32-35). IV streptokinase in doses of 100,000 units/hr results
in successful intravascular clot lysis (34). However, maintenance of systemic streptokinase levels in this therapeutic range
regularly results in unwanted bleeding at distal sites, particularly recent surgical incisions and needle puncture sites (34).
The purpose of IA administration is to maximize drag levels
at the target site, while minimizing systemic levels. IA streptokinase in doses of 10,000 units/hr results in the same degree of
intravascular clot lysis as 100,000 units/hr administered systemically, without the unwanted systemic side effects (34). IA
streptokinase infusion has been proven effective in clot lysis
(without distal hemonhagic complications) at a number of different locations, including peripheral and pulmonary arterial
circulation (32), peripheral arterial grafts, renal dialysis accesses (33), and coronary circulation (35).
The catheter used for streptokinase infusion may lie for a
fairly long period within the relatively stagnant column of blood
proximal to an obstracting thrombus. Simultaneous systemic
heparinization is therefore recommended to prevent new thrombus formation on the catheter (33).
Zeumer et al have reported five cases of IA streptokinase infusion for angiographically proven basilar artery thrombosis (19).
Three of these five patients demonstrated dramatic functional
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improvement and prevention of further ischemic necrosis. One
patient died, and one remained "locked in," unchanged from
the preinfusion state. A dose of 100,000 units/hr for two hours
was used in all patients with no CT evidence of intracranial hemonhage (19).
In the case we report, autopsy revealed no evidence of significant atherosclerotic plaque formation in the intracranial vertebrobasilar system. Therefore, we postulate that the most likely
cause of thrombus formation is stasis due to massive basilar ectasia (33). Because of tiie grave namre of this patient's problem
and the rapid rate of clinical deterioration, we felt that anything
less than a maximally aggressive therapeutic approach would
produce a certaiifly fatal outcome. At autopsy, embolic occlusion ofthe left posterior cerebral artery and extensive brain stem
infarction were found. We postulate that die large basilar thrombus was "broken up" by streptokinase infusion into multiple
smaller clots which embolized distally.
Because ofthe small number of cases reported,riskshave not
been established for this procedure, but certainly embolization
of basilar branches due to clot "break up" would be a major theoretical risk. Intracranial hemonhage would be a second major
theoreticalrisk;however, this was not seen in our case, nor in the
cases reported by Zeumer (19).
The goal in intracranial arterial clot lysis must be dissolution
of the clot exterior, layer by layer, peeling it like an "onion
skin." Formation of smaller clot fragments, which migrate distally, producing embolic tissue infarction may be tolerated in the
peripheral vasculature but not in the central nervous system. Further experimental work must be done to suitably modify this
technique for widespread use in central nervous system intraarterial thrombolysis.

IVansluminal detachable balloon occlusion of carotidcavernous fistula
The term carotid-cavemous (CC) fistula is used to describe
two anatomically distinct vascular abnormalities. In both cases,
an abnormalfistulousconnection exists between arteries adjacent to the cavemous sinus and the sinus itself. This fistulous
channel produces abnormal shunting of arterial blood directly
into the cavemous sinus (10).
When the arterial supply to the fistula is from small dural
branches of the ICA or the ECA, the rate and volume of flow is
often minimal. This type of carotid-cavernous fistula usually
does not pose a serious clinical problem, and often is merely an
incidental finding at cerebral angiography. Spontaneous closure
ofthis type offistulais the rale and,flierefore,no form of fi-eatment is recommended (10).
IL however, the arterial supply to the fistula is through a tear
in the cavemous ICA itselL then flow through thefistulais often
of high rate and volume. This type of CC fistula may produce
severe clinical symptoms. The rapid arterial to venous shunting
elevates the pressure within the cavemous sinus and the venous
channels which normally drain into or out of the sinus (10). Elevation of pressure within the cavemous sinus may result in dysfunction of cranial nerves 3, 4, 6, and 5 (particularly the first
division). Elevation of venous pressure within the orbit may produce exophthalmus and, more importantly, vision loss. These
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symptoms are most commonly seen ipsilateral to thefistulabut
due to normally present transcavemous venous channels may be
bilateral or rarely contralateral to the fistula. This high-flow type
of CCfistulamost commonly results from trauma or from spontaneous rapture of a cavemous ICA aneurysm. These, in general, do not close spontaneously, andti-eatmentis recommended
because of the danger of permanent blindness and/or ocular
palsy (10). Carotid-cavemous fistulas that drain predominantly
posteriorly may produce a cavemous sinus syndrome and a loud
brait, without significant orbital symptoms.
A variety of approaches have been used to treat high-flow CC
fistulae. The list includes simple ligation of the ipsilateral ICA
or common carotid artery in the neck, trapping of the ICA with
or without fistula embolization, or intraluminal balloon occlusion of the cavernous ICA (11,36). Copper wires have been
placed into the cavemous sinus with or without electric cunent
to induce thrombosis (36). A procedure recentiy described by
Diaz et al involves ICAti-appingcombined with an ipsilateral
bypass of the superficial temporal to the middle cerebral artery
in the sylvianfissure(11,36).
Detachable baUoon occlusion of the fistula itself is theoretically the best procedure for treatment of this condition
because the fistula is closed without occluding the ipsilateral
ICA (11).
Two different types of detachable balloons have been developed. Latex balloons were developed first but have been supplanted in many centers by the silicone balloon we have described (11,12).
The latex balloon must be hand-tied (often difficult and time
consuming) with a ligature at the end of a single lumen catheter
This balloon must be maneuvered into the fistula and detached
with a coaxially placed 8 French outer single lumen catheter It
is often difficult to maneuver an 8 French catheter into the cavernous carotid artery, and the risk of damage to the vessel wall
from a catheter this large is significant. A second catheter must
be placed in the opposite groin and placed in the ipsilateral
carotid artery to perform diagnostic angiographic runs. The
balloon ligature is inherently weak, and partial or complete
balloon deflation is a problem. Latex balloons also incite tissue
reaction (12).
We prefer the silicone detachable balloons because they are
more maneuverable, have less premature deflation, come ready
to use from the manufacturer, do not require placement of a second catheter in the opposite groin, and incite little if any tissue
reaction (12). The one advantage latex balloons have is greater
distensibility. Because they can be inflated to larger diameter,
one latex balloon is usually sufficient to achieve fismla closure.
Conversely, up to six silicone balloons may be required to close
or sufficiently reduce fistula flow.
Use of either silicone or latex balloons is not without risk. The
most serious potential complication is distal embolization of the
intracranial carotid circulation by a prematurely detached or deflated balloon, which may produce stroke. Palsy of cranial
nerves 3, 4, 6, 5 (first division), and 7 have been reported
(11-13). These are nearly always temporary when they do occur
If a balloon is overinflated in the cavemous sinus and later deflates, a false aneurysm may be produced. Trauma to the low
cervical ICA by the outer 9 French coaxial cadieter may rarely
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cause perforation, false aneurysm, dissection, or occlusion
(1L12).
Angiographically complete fistula closure is not commonly
achieved. Silicone balloons are individually placed until
the fistula flow is slowed significantly, and the subjective brait
experienced by the patient disappears. When this end point
is achieved, the cavernous sinus will usually thrombos spontaneously within weeks. The fistula will then not recur, even
with balloon deflation. This instant and dramatic resolution in
symptoms can be one of the most elegant and gratifying procedures in medicine.

Summary
We have had experience with four different types of nonembolization interventional neuroradiologic procedures at Henry
Ford Hospital. Detachable balloon occlusion of CC fistula is an
elegant procedure with well-documented clinical efficacy. PTA
of the ECA, intracarotid BCNU infusion for glioblastoma, and
intraarterial streptokinase for basilar thrombosis are relatively
new or experimental procedures and, therefore, not widely reported in the literature. The full range of clinical applicability of
the latter three procedures has yet to be realized.
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